rdf-syntax-grammar
mods:
  schema location: http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-2.xsd
  title info:
    title: Nicotine Psychopharmacology
  title info:
    title: With contributions by numerous experts
  name:
    name part: Henningfield, Jack E.
    role:
      role term: editor.
  name:
    name part: London, Edythe D.
    role:
      role term: editor.
  name:
    name part: Pogun, Sakire.
    role:
      role term: editor.
  name:
    name part: SpringerLink (Online service)
  type of resource: text
  origin info:
    place:
      place term: gw
    date issued: 2009
    issuance: monographic
  language:
    language term: eng
  physical description:
    form: electronic
    form: electronic resource
    reformatting quality: access
    form: remote
    extent: XIV, 544 p. 56 illus., 16 illus. in color. online resource.
  abstract: The fact that tobacco ingestion can affect how people feel and think has been known for millennia, placing the plant among those used spiritually, honori?cally, and habitually (Corti 1931; Wilbert 1987). However, the conclusion that nicotine - counted for many of these psychopharmacological effects did not emerge until the nineteenth century (Langley 1905). This was elegantly described by Lewin in 1931 as follows: “The decisive factor in the effects of tobacco, desired or undesired, is nicotine. . . ”(Lewin 1998). The use of nicotine as a pharmacological probe to und- stand physiological functioning at the dawn of the twentieth century was a landmark in the birth of modern neuropharmacology (Limbird 2004; Halliwell 2007), and led the pioneering researcher John Langley to conclude that there must exist some “- ceptive substance” to explain the diverse actions of various substances, including nicotine, when applied to muscle tissue (Langley 1905). Research on tobacco and nicotine progressed throughout the twentieth century, but much of this was from a general pharmacological and toxicological rather than a psychopharmacological perspective (Larson et al. 1961). There was some attention to the effects related to addiction, such as euphoria (Johnston 1941), tolerance (Lewin 1931), and withdrawal (Finnegan et al. 1945), but outside of research supported by the tobacco industry, addiction and psychopharmacology were not major foci for research (Slade et al. 1995; Hurt and Robertson 1998; Henning?eld et al. 2006; Henning?eld and Hartel 1999; Larson et al. 1961).
  table of contents: Nicotine and Tobacco Consumption: Measurement and Trends -- Global Patterns of Nicotine and Tobacco Consumption -- Nicotine Chemistry, Metabolism, Kinetics and Biomarkers -- Nicotine Content and Delivery Across Tobacco Products -- Nicotine Pharmacology and Mechanisms of Action -- The Road to Discovery of Neuronal Nicotinic Cholinergic Receptor Subtypes -- Magnetic Resonance Imaging Studies of Cigarette Smoking -- In vivo Brain Imaging of Human Exposure to Nicotine and Tobacco -- Molecular and Cellular Mechanisms of Action of Nicotine in the CNS -- The Neuronal Pathways Mediating the Behavioral and Addictive Properties of Nicotine -- Molecular Genetics of Nicotine Metabolism -- Sex Differences in Nicotine Action -- Nicotine Psychopharmacology -- Recognising Nicotine: The Neurobiological Basis of Nicotine Discrimination -- Effects of Nicotine in Experimental Animals and Humans: An Update on Addictive Properties -- Discriminative Stimulus Effects of Nicotine in Humans -- Rodent Models of Nicotine Withdrawal Syndrome -- Approaches, Challenges, and Experience in Assessing Free Nicotine -- Approaches, Challenges, and Experience in Assessing Free Nicotine -- Tobacco Industry Manipulation of Nicotine Dosing -- Pharmacotherapy for Tobacco Dependence -- Nicotine Psychopharmacology: Policy and Regulatory.
  note: edited by Jack E. Henningfield, Edythe D. London, Sakire Pogun.
  subject:
    topic: Medicine
  subject:
    topic: Neurosciences
  subject:
    topic: Pharmacology
  subject:
    topic: Psychiatry
  subject:
    topic: Psychopharmacology
  subject:
    topic: Neuropsychology
  subject:
    topic: Biomedicine
  subject:
    topic: Pharmacology/Toxicology
  subject:
    topic: Psychiatry
  subject:
    topic: Neurosciences
  subject:
    topic: Psychopharmacology
  subject:
    topic: Neuropsychology
  classification: RM1-950
  classification: 615
  related item:
    title info:
      title: Springer eBooks
  related item:
    title info:
      title: Handbook of Experimental Pharmacology, 192
  identifier: 9783540692485
  identifier: http://dx.doi.org/10.1007/978-3-540-69248-5
  record info:
    record creation date: 100301
    record change date: 20151204153856.0
    record identifier: 978-3-540-69248-5